Skip to content

Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript

  • by
  • 1 min read

Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript March 1, 2024 Biodesix, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.11. BDSX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. […]

Join the conversation

Your email address will not be published. Required fields are marked *